|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2007-9-27
|
|
pubmed:abstractText |
The safety and efficacy of NaP tablets have not been compared with 2L PEG lavage solution. A multicenter, investigator-blinded study was conducted to compare the colon-cleansing efficacy of a new NaP tablet formulation with that of 2L PEG solution plus bisacodyl tablets in adults undergoing colonoscopy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2238-46
|
|
pubmed:dateRevised |
2008-6-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17573796-Administration, Oral,
pubmed-meshheading:17573796-Adolescent,
pubmed-meshheading:17573796-Adult,
pubmed-meshheading:17573796-Aged,
pubmed-meshheading:17573796-Bisacodyl,
pubmed-meshheading:17573796-Cathartics,
pubmed-meshheading:17573796-Colonoscopy,
pubmed-meshheading:17573796-Drug Administration Schedule,
pubmed-meshheading:17573796-Female,
pubmed-meshheading:17573796-Humans,
pubmed-meshheading:17573796-Male,
pubmed-meshheading:17573796-Middle Aged,
pubmed-meshheading:17573796-Phosphates,
pubmed-meshheading:17573796-Polyethylene Glycols,
pubmed-meshheading:17573796-Single-Blind Method,
pubmed-meshheading:17573796-Surface-Active Agents,
pubmed-meshheading:17573796-Tablets,
pubmed-meshheading:17573796-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing.
|
|
pubmed:affiliation |
Rockford Gastroenterology Associates, Rockford, Illinois, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
